SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/09/22 Commonwealth Income & Gro… VII LP 10-Q 6/30/22 54:2.2M Blueprint/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 452K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 21K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 20K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 17K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 17K 11: R1 Cover HTML 65K 12: R2 Condensed Balance Sheets HTML 92K 13: R3 Condensed Balance Sheets (Parenthetical) HTML 24K 14: R4 Condensed Statements of Operations HTML 81K 15: R5 Condensed Statement of Partners Capital HTML 48K 16: R6 Condensed Statements of Cash Flow (Unaudited) HTML 41K 17: R7 Business HTML 21K 18: R8 Summary of Significant Accounting Policies HTML 30K 19: R9 Information Technology Medical Technology HTML 44K Telecommunications Technology Inventory Management Equipment (Equipment) 20: R10 Investment in COF 2 HTML 28K 21: R11 Related Party Transactions HTML 36K 22: R12 Notes Payable HTML 34K 23: R13 Supplemental Cash Flow Information HTML 24K 24: R14 Commitments and Contingencies HTML 28K 25: R15 Summary of Significant Accounting Policies HTML 38K (Policies) 26: R16 Summary of Significant Accounting Policies HTML 20K (Tables) 27: R17 Information Technology Medical Technology HTML 41K Telecommunications Technology Inventory Management Equipment (Tables) 28: R18 Investment in COF 2 (Tables) HTML 27K 29: R19 Related Party Transactions (Tables) HTML 34K 30: R20 Notes Payable (Tables) HTML 29K 31: R21 Supplemental Cash Flow Information (Tables) HTML 24K 32: R22 Business (Details Narrative) HTML 23K 33: R23 Summary of Significant Accounting Policies HTML 22K (Details) 34: R24 Summary of Significant Accounting Policies HTML 21K (Details Narrative) 35: R25 Information Technology Medical Technology HTML 29K Telecommunications Technology Inventory Management Equipment (Details) 36: R26 Information Technology Medical Technology HTML 23K Telecommunications Technology Inventory Management Equipment (Details 1) 37: R27 Information Technology Medical Technology HTML 25K Telecommunications Technology Inventory Management Equipment (Details 2) 38: R28 Information Technology Medical Technology HTML 25K Telecommunications Technology Inventory Management Equipment (Details 3) 39: R29 Information Technology Medical Technology HTML 27K Telecommunications Technology Inventory Management Equipment (Details Narrative) 40: R30 Investment in COF 2 (Details) HTML 26K 41: R31 Investment in COF 2 (Details Narrative) HTML 23K 42: R32 Related Party Transactions (Details) HTML 24K 43: R33 Notes Payable (Details) HTML 34K 44: R34 Notes Payable (Details 1) HTML 28K 45: R35 Notes Payable (Details Narrative) HTML 18K 46: R36 Supplemental Cash Flow Information (Details) HTML 18K 47: R37 Supplemental Cash Flow Information (Details 1) HTML 19K 48: R38 Supplemental Cash Flow Information (Details HTML 18K Narrative) 49: R39 Commitments and Contingencies (Details Narrative) HTML 31K 52: XML IDEA XML File -- Filing Summary XML 94K 50: XML XBRL Instance -- cigf_10q_htm XML 435K 51: EXCEL IDEA Workbook of Financial Reports XLSX 73K 8: EX-101.CAL XBRL Calculations -- cigf-20220630_cal XML 98K 10: EX-101.DEF XBRL Definitions -- cigf-20220630_def XML 103K 7: EX-101.LAB XBRL Labels -- cigf-20220630_lab XML 408K 9: EX-101.PRE XBRL Presentations -- cigf-20220630_pre XML 299K 6: EX-101.SCH XBRL Schema -- cigf-20220630 XSD 106K 53: JSON XBRL Instance as JSON Data -- MetaLinks 175± 237K 54: ZIP XBRL Zipped Folder -- 0001654954-22-012315-xbrl Zip 105K
EXHIBIT 32.1
32.1 SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Commonwealth Income & Growth Fund VII, (the “Company”) on Form 10-Q for the quarter ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kimberly A. Springsteen-Abbott, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
| |
Kimberly A. Springsteen-Abbott Chief Executive Officer |
|
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed as of: | 9/9/22 | None on these Dates | ||
Filed on: | 9/8/22 | |||
For Period end: | 6/30/22 | |||
List all Filings |